{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:44:33Z","timestamp":1782719073271,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Program of Guangzhou, China","award":["2024A03J1160"],"award-info":[{"award-number":["2024A03J1160"]}]},{"name":"the Science and Technology Program of Guangzhou, China","award":["2024A03J1157"],"award-info":[{"award-number":["2024A03J1157"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82402418"],"award-info":[{"award-number":["No.82402418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Medical Science and Technology Research Funding","award":["A2023233"],"award-info":[{"award-number":["A2023233"]}]},{"name":"Guangdong Medical Science and Technology Research Funding","award":["B2023128"],"award-info":[{"award-number":["B2023128"]}]},{"name":"the Plan on Enhancing Scientific Research in GMU","award":["GMUCR2025-02016"],"award-info":[{"award-number":["GMUCR2025-02016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07827-0","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T01:16:56Z","timestamp":1774228616000},"page":"5172-5184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]FAPI PET\/CT outperforms [18F]FDG in distinguishing nodal immune flare from lymph node metastases during immunotherapy for lung cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Youcai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-5687","authenticated-orcid":false,"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"7827_CR1","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1158\/1078-0432.CCR-18-1538","volume":"25","author":"DB Doroshow","year":"2019","unstructured":"Doroshow DB, Sanmamed MF, Hastings K, Politi K, Rimm DL, Chen L, et al. Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes. Clin Cancer Res. 2019;25:4592\u2013602. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1538.","journal-title":"Clin Cancer Res"},{"key":"7827_CR2","doi-asserted-by":"publisher","first-page":"e2413125","DOI":"10.1002\/advs.202413125","volume":"12","author":"L Wu","year":"2025","unstructured":"Wu L, Zhang Z, Jiang C, Li L, Sun X, Bai M, et al. Integration of Circulating Tumor DNA and Metabolic Parameters on (18)F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung Cancer. Adv Sci (Weinh). 2025;12:e2413125. https:\/\/doi.org\/10.1002\/advs.202413125.","journal-title":"Adv Sci (Weinh)"},{"key":"7827_CR3","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1200\/JCO.22.01989","volume":"41","author":"MC Garassino","year":"2023","unstructured":"Garassino MC, Gadgeel S, Speranza G, Felip E, Esteban E, Domine M, et al. Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. J Clin Oncol. 2023;41:1992\u20138. https:\/\/doi.org\/10.1200\/JCO.22.01989.","journal-title":"J Clin Oncol"},{"key":"7827_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/JCO.22.01990","volume":"41","author":"S Novello","year":"2023","unstructured":"Novello S, Kowalski DM, Luft A, Gumus M, Vicente D, Mazieres J, et al. Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study. J Clin Oncol. 2023;41:1999\u20132006. https:\/\/doi.org\/10.1200\/JCO.22.01990.","journal-title":"J Clin Oncol"},{"key":"7827_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018;378:158\u201368. https:\/\/doi.org\/10.1056\/NEJMra1703481.","journal-title":"N Engl J Med"},{"key":"7827_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chavez A, Keegan N, Khamashta MA, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6:38. https:\/\/doi.org\/10.1038\/s41572-020-0160-6.","journal-title":"Nat Rev Dis Primers"},{"key":"7827_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","volume":"35","author":"J Naidoo","year":"2017","unstructured":"Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, et al. Pneumonitis in Patients Treated With Anti-Programmed Death-1\/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2017;35:709\u201317. https:\/\/doi.org\/10.1200\/JCO.2016.68.2005.","journal-title":"J Clin Oncol"},{"key":"7827_CR8","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/s41467-021-25188-0","volume":"12","author":"T Cascone","year":"2021","unstructured":"Cascone T, Weissferdt A, Godoy MCB, William WN Jr., Leung CH, Lin HY, et al. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nat Commun. 2021;12:5045. https:\/\/doi.org\/10.1038\/s41467-021-25188-0.","journal-title":"Nat Commun"},{"key":"7827_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1148\/radiol.210518","volume":"306","author":"L Dercle","year":"2023","unstructured":"Dercle L, Sun S, Seban RD, Mekki A, Sun R, Tselikas L, et al. Emerging and Evolving Concepts in Cancer Immunotherapy Imaging. Radiology. 2023;306:32\u201346. https:\/\/doi.org\/10.1148\/radiol.210518.","journal-title":"Radiology"},{"key":"7827_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1148\/radiol.2018180572","volume":"289","author":"SC Cheshire","year":"2018","unstructured":"Cheshire SC, Board RE, Lewis AR, Gudur LD, Dobson MJ. Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma. Radiology. 2018;289:564\u20137. https:\/\/doi.org\/10.1148\/radiol.2018180572.","journal-title":"Radiology"},{"key":"7827_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1148\/rg.2021200093","volume":"41","author":"LB Costa","year":"2021","unstructured":"Costa LB, Queiroz MA, Barbosa FG, Nunes RF, Zaniboni EC, Ruiz MM, et al. Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism. Radiographics. 2021;41:120\u201343. https:\/\/doi.org\/10.1148\/rg.2021200093.","journal-title":"Radiographics"},{"key":"7827_CR12","doi-asserted-by":"publisher","first-page":"e00542","DOI":"10.1002\/rcr2.542","volume":"8","author":"E Sanderson","year":"2020","unstructured":"Sanderson E, Wimaleswaran H, Senko C, White S, McDonald CF. Durvalumab induced sarcoid-like pulmonary lymphadenopathy. Respirol Case Rep. 2020;8:e00542. https:\/\/doi.org\/10.1002\/rcr2.542.","journal-title":"Respirol Case Rep"},{"key":"7827_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60:801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"7827_CR14","doi-asserted-by":"publisher","first-page":"e222785","DOI":"10.1148\/radiol.222785","volume":"308","author":"Y Wei","year":"2023","unstructured":"Wei Y, Ma L, Li P, Lu J, Ren J, Yan S, et al. FAPI Compared with FDG PET\/CT for Diagnosis of Primary and Metastatic Lung Cancer. Radiology. 2023;308:e222785. https:\/\/doi.org\/10.1148\/radiol.222785.","journal-title":"Radiology"},{"key":"7827_CR15","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, et al. Higher accuracy of [(68) Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[(18)F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging. 2022;49:2983\u201393. https:\/\/doi.org\/10.1007\/s00259-022-05818-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7827_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40644-024-00701-y","volume":"24","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang Y, Guo Z, Hou P, Lv J, Ke M, et al. [(18)F]FAPI adds value to [(18)F]FDG PET\/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study. Cancer Imaging. 2024;24:68. https:\/\/doi.org\/10.1186\/s40644-024-00701-y.","journal-title":"Cancer Imaging"},{"key":"7827_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1148\/rg.346130097","volume":"34","author":"AH El-Sherief","year":"2014","unstructured":"El-Sherief AH, Lau CT, Wu CC, Drake RL, Abbott GF, Rice TW. International association for the study of lung cancer (IASLC) lymph node map: radiologic review with CT illustration. Radiographics. 2014;34:1680\u201391. https:\/\/doi.org\/10.1148\/rg.346130097.","journal-title":"Radiographics"},{"key":"7827_CR18","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pages","year":"2018","unstructured":"Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)30789-X.","journal-title":"Lancet"},{"key":"7827_CR19","doi-asserted-by":"publisher","first-page":"104452","DOI":"10.1016\/j.ebiom.2023.104452","volume":"88","author":"A Mezheyeuski","year":"2023","unstructured":"Mezheyeuski A, Backman M, Mattsson J, Martin-Bernabe A, Larsson C, Hrynchyk I, et al. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. EBioMedicine. 2023;88:104452. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104452.","journal-title":"EBioMedicine"},{"key":"7827_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2967\/jnumed.123.266806","volume":"65","author":"C Li","year":"2024","unstructured":"Li C, Chen Q, Tian Y, Chen J, Xu K, Xiao Z, et al. (68)Ga-FAPI-04 PET\/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression. J Nucl Med. 2024;65:527\u201332. https:\/\/doi.org\/10.2967\/jnumed.123.266806.","journal-title":"J Nucl Med"},{"key":"7827_CR21","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1097\/RLU.0000000000002453","volume":"44","author":"T Nobashi","year":"2019","unstructured":"Nobashi T, Baratto L, Reddy SA, Srinivas S, Toriihara A, Hatami N, et al. Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET\/CT. Clin Nucl Med. 2019;44:e272\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000002453.","journal-title":"Clin Nucl Med"},{"key":"7827_CR22","doi-asserted-by":"publisher","first-page":"e220122","DOI":"10.1148\/rg.220122","volume":"43","author":"AS Parihar","year":"2023","unstructured":"Parihar AS, Dehdashti F, Wahl RL. FDG PET\/CT-based Response Assessment in Malignancies. Radiographics. 2023;43:e220122. https:\/\/doi.org\/10.1148\/rg.220122.","journal-title":"Radiographics"},{"key":"7827_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480\u2013508. https:\/\/doi.org\/10.2967\/jnumed.107.047787.","journal-title":"J Nucl Med"},{"key":"7827_CR24","doi-asserted-by":"publisher","first-page":"e08225","DOI":"10.1002\/advs.202508225","volume":"12","author":"H Wu","year":"2025","unstructured":"Wu H, Li C, Li L, Tian Y, Xiao Z, Huang Y, et al. Integrin alphavbeta6-Targeted PET\/CT Imaging of Non-Small Cell Lung Cancer with [(68)Ga]Ga-Trivehexin: Improved Preoperative Lymph Node Staging and Association with Immunohistochemistry. Adv Sci (Weinh). 2025;12:e08225. https:\/\/doi.org\/10.1002\/advs.202508225.","journal-title":"Adv Sci (Weinh)"},{"key":"7827_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2967\/jnumed.124.268289","volume":"66","author":"AS Parihar","year":"2025","unstructured":"Parihar AS, Pant N, Heidari P, Fong L, Iravani A. Approaches to Imaging Immune Activation Using PET. J Nucl Med. 2025;66:839\u201347. https:\/\/doi.org\/10.2967\/jnumed.124.268289.","journal-title":"J Nucl Med"},{"key":"7827_CR26","doi-asserted-by":"publisher","unstructured":"Pezzana S, Blaess S, Traenkle B, Schaefer A, Ruoff L, Tako B et al. PET-based immunomapping of intratumoral CD4(+) cells to monitor acquired resistance to checkpoint inhibitors. Sci Adv. 2025;11:eadw1924. https:\/\/doi.org\/10.1126\/sciadv.adw1924.","DOI":"10.1126\/sciadv.adw"},{"key":"7827_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2967\/jnumed.124.269002","volume":"66","author":"TA Hope","year":"2025","unstructured":"Hope TA, Calais J, Goenka AH, Haberkorn U, Konijnenberg M, McConathy J, et al. SNMMI Procedure Standard\/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET. J Nucl Med. 2025;66:26\u201333. https:\/\/doi.org\/10.2967\/jnumed.124.269002.","journal-title":"J Nucl Med"},{"key":"7827_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","volume":"26","author":"KM Pabst","year":"2025","unstructured":"Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Kuper AT, et al. [(68)Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial. Lancet Oncol. 2025;26:1204\u201314. https:\/\/doi.org\/10.1016\/S1470-2045(25)00299-2.","journal-title":"Lancet Oncol"},{"key":"7827_CR29","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00259-024-06669-y","volume":"51","author":"YK Kang","year":"2024","unstructured":"Kang YK, Na KJ, Park J, Kwak N, Lee YS, Choi H, et al. Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [(68)Ga]FAPI-46 PET\/CT: a prospective pilot study. Eur J Nucl Med Mol Imaging. 2024;51:2409\u201319. https:\/\/doi.org\/10.1007\/s00259-024-06669-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7827_CR30","doi-asserted-by":"publisher","first-page":"e220749","DOI":"10.1148\/radiol.220749","volume":"306","author":"Y Mori","year":"2023","unstructured":"Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease. Radiology. 2023;306:e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","journal-title":"Radiology"},{"key":"7827_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jcmg.2025.05.021","volume":"18","author":"S Liang","year":"2025","unstructured":"Liang S, Hou P, Wang X, Liang W, Zhong S, Zhao R, et al. Comparison of (18)F-FAPI-42 PET for Detecting Cardiac Fibroblast Activation in Dilated Cardiomyopathy With Histopathology and CMR. JACC Cardiovasc Imaging. 2025;18:997\u20131009. https:\/\/doi.org\/10.1016\/j.jcmg.2025.05.021.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7827_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2967\/jnumed.124.268943","volume":"66","author":"S Liu","year":"2025","unstructured":"Liu S, Pan Q, Zhang H, Peng L, Zhang W, Feng Y, et al. Differences in Fibroinflammatory Activity Shown on (68)Ga-FAPI-04 and (18)F-FDG PET\/CT in the Two Subtypes of IgG4-Related Disease. J Nucl Med. 2025;66:634\u201340. https:\/\/doi.org\/10.2967\/jnumed.124.268943.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07827-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:47:39Z","timestamp":1782715659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07827-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7827"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07827-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article was modified to add the following article note: Youcai Li, Fang Wu, and Meijuan Zhou contributed equally to this work and are co-first authors.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Clinical Research Ethics Committee of Guangzhou Medical University\u2019s First Affiliated Hospital and the Chinese Clinical Trial Registry (ChiCTR2100044944).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of all the images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}